Results 181 to 190 of about 6,539 (194)

Synthesis of Novel Analogs of Cabergoline: Improving Cardiovascular Safety by Removing 5-HT2B Receptor Agonism

ACS Medicinal Chemistry Letters, 2013
Michael A Walters, Peter Dosa, Suck Won Kim   +2 more
exaly  

Dopamine Receptor Expression and Function in Clinically Nonfunctioning Pituitary Tumors: Comparison with the Effectiveness of Cabergoline Treatment

Journal of Clinical Endocrinology and Metabolism, 2004
Annamaria Colao, Carmela Matrone, Lucio Annunziato   +2 more
exaly  

Cabergoline

Reactions Weekly, 2013
openaire   +1 more source

Determination of cabergoline and -dopa in human plasma using liquid chromatography–tandem mass spectrometry

Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences, 2003
Fumiyo Kasuya
exaly  

In vivo interaction of cabergoline with rat brain dopamine receptors labelled with [3H]N-n-propylnorapomorphine

European Journal of Pharmacology, 1990
D Barone, C Efthymiopoulos, Domenico Barone   +2 more
exaly  

Cabergoline

Reactions Weekly, 1999
openaire   +1 more source

The Long-Acting Dopamine Receptor Agonist Cabergoline in Early Parkinson???s Disease

CNS Drugs, 2012
Jean-Louis Montastruc, Agatino Battaglia, OSCAR Gershanik   +2 more
exaly  

Cabergoline

Reactions Weekly, 2017
openaire   +2 more sources

Cabergoline in Parkinson's disease complicated by motor fluctuations

Movement Disorders, 1996
T Caraceni, P Giovannini
exaly  

Cabergoline

Reactions Weekly, 2010
openaire   +2 more sources